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ABSTRACT
The functions of Ataxia telangiectasia and Rad-3 related protein (ATR) is very much
important in a cell, as it is a DNA damage response protein, which plays an important role
in cell division, DNA repair and apoptosis. This protein helps in proliferation in the actively
DNA dividing normal cells and in cancer cells. The functions of ATR in a proliferating
cell are well studied and known to involve regulation of replication fork and cell cycle
progression after DNA damage. Whereas, in a non-replicating cell, the functions of ATR
are not so well known. In the human body, most of the cells are in a non-replicating state,
which do not actively replicate DNA, and include cells in a quiescent, senescent, and
terminally differentiated state. What could be the function of ATR in these cells is
something that nobody has ever looked at and is important because differentiated cells are
routinely exposed to DNA damaging agents. ATR inhibitors are used as combination
treatments in DNA damage-based anti-cancer therapies to inhibit pro-survival functions of
ATR in cancer cells. Some of the studies show that, inhibition of ATR in non-diving cells
would show an opposite effect than in the diving cells in response to DNA Damage caused
by UVB. Hence, we have conducted experiments to test if inhibition of ATR would show
a pro-survival role in differentiated keratinocytes. DNA damage has been induced using
UV-B radiation and ATR is activated in both differentiated N-TERT keratinocytes in vitro
and in human skin.
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1.0 INTRODUCTION
1.1 ULTRAVIOLET RADIATION:
Ultraviolet (UV) radiation is a form of electromagnetic radiation which is naturally
produced by the sun and is also generated artificially by man-made forms of light, for
example: tanning beds, welding torches. The radiation has been characterized into various
energy levels based on their frequency.1 UV-rays are considered to be in the middle of the
spectra2. These UV rays are characterized into different types based the energy levels. If
these rays have higher energy levels, they are considered to be in the form ionizing
radiation, which would have capability of ionizing atoms and molecules. This higher
energy radiations can even damage the DNA inside the cells, which would have many
negative effects over the cells.3 Based on the cell type, the implications that the DNA
damage would cause will be differed.
These UV-Rays are divided into three types:
1.1.1

UV-A radiation:

This radiation has the lowest energy levels than the other three radiation sources.
Hence, this radiation has little less harmful effects. UVA is believed to cause aging
in the skin cells leading to wrinkle formation, can indirectly cause DNA damage
which rarely leading to cancer. The UVA radiation can enter up to the dermal layer
of the skin.4 (Figure 1)
1.1.2

UV-B radiation:

1

This radiation has more energy than the UVA radiation. The UVB radiation has the
capability of affecting the skin by causing sunburns, can cause heavy DNA damage
leading to cancer. UVB is responsible for most of the skin cancers caused by UV
radiation. The UVB radiation can enter up to the epidermal layer of the skin.4
(Figure 1)
1.1.3

UV-C radiation:

The UVC radiation has the highest energy levels than all of the UV radiations. Due
the same reason, the radiation would react with the ozone layer in the atmosphere
and will not be able to reach the earth surface.4 (Figure 1)
The most common DNA-damaging agent in the atmosphere is ultraviolet radiation (UVR).
UVR damages to DNA cause misincorporation or alteration of bases during replication,
hydrolytic and/or oxidative damage caused by free radicals and reactive oxygen species,
single and double strand breaks (DSBs), and the development of CPDs and 6-4 PPs lesions,
all of which compromise genomic integrity.5,6

2

Figure 1: Depth of penetration of different wavelengths of UV light into human skin.
Based on the damage there are certain types of DNA damage repair mechanisms that get
activated after the damage. Nucleotide excision repair (NER), base excision repair (BER),
mismatch

repair

(MMR),

non-homologous

end

joining

(NHEJ),

homologous

recombination (HR) repair, and other additional responses including damage tolerance
(dimer bypass), checkpoint activation, and programmed cell death or apoptosis are all
initiated by the cells in response to these damages. The DNA Damage Responses (DDR)
are a group of cellular responses that detect damage, trigger signals to detect the damage,
and initiate repair.1-3

3

1.2 DNA DAMAGE REPAIR MECHANISM:
The DNA repair mechanisms play a vital role in protecting the cells from various damages
caused by different DNA damaging agents. Based on the type of damage, either of the fiverepair mechanisms would become activated to protect the cell.
The below table would show the corresponding DNA repair mechanism based on the DNA
damage occurred.6,7
TABLE 1
Lesion

Cause

Repair Mechanism

CPD, 6-4PP(1)

Sunlight

NER

Bulky adducts(2)

Food, cigarette smoke

NER

Intrastrand crosslinks

Chemotherapy (e.g., Cis-Pt)

NER

8-oxo-dG(3)

ROS(4), respiration

BER

Thymine glycol(3)

ROS(4), respiration

BER

N7-Alkyl-dG, N3-Alkyl-dA

Food, pollutants

BER

O6-Alkyl-dG

Food, pollutants

DR(5), BER?

5-methyl-dC

DNMT(6)

BER/AID-BER/NER?(7)

Uracil, (Hypo)Xanthine

Spontaneous deamination

BER

Abasic site

Spontaneous hydrolysis

BER

Single-strand breaks

Ionizing radiation, ROS

Ligation, BER

4

Double-strand breaks

Ionizing radiation, ROS, VDJ-rec

HR, NHEJ

Tyrosyl-3′DNA(8)

Topo-I inhibition, ROS

SSBR

Mismatches

Replication errors

MMR

Small insertion/deletions

Replication slippage

MMR

Interstrand crosslinks

Chemotherapy

ICLR/ HR?

Table 1: Induction of DNA lesions and corresponding repair pathway.
1. CPD: cyclobutane pyrimidine dimer; 6-4 PP: 6-4 pyrimidine-pyrimidone
photoproduct
2. A large group of chemicals conjugated to bases that cause DNA helix
destabilization such as: Benzo[α]pyrene (a polycylic aromatic hydrocarbon);
Aflatoxins (present in fungal food contaminations); and Nitrosamines (tobacco
smoke).
3. A large group of different oxidation products affecting either the base or the
phosphate-sugar backbone of which 8-oxo-dG is the most abundant.
4.

ROS:

reactive

oxygen

species,

produced

as

side-product

of

respiration/metabolism and ionizing radiation.
5. DR: direct reversal, involving the suicide enzyme MGMT.
6. DNMT: DNA methyltransferase, functions in epigenetic gene-expression control
(e.g., at CpG islands).
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7. The mechanism of 5-Me-C repair/conversion is a matter of debate. Recently, a
GADD45a-dependent NER reaction was suggested. 42
8. Proteolytic degradation of conjugated Topo-I to 3′DNA termini creates tyrosyl3′DNA bonds, resolved by TDP1.43
Table Reference:
DNA Damage Response - Giuseppina Giglia-Mari,1,2,3 Alika Zotter and Wim
Vermeulen
1.2.1 BASE EXCISION REPAIR:
BER corrects oxidative, deamination, alkylation, and a basic single base damage to the
DNA helix that are not viewed as major distortions. This repair process is most involved
in the nucleus during the G1 phase of the cell cycle. Chromatin remodeling at the DNA
damage site is accompanied by lesion identification by a DNA glycosylase in BER
transactions. Until the single strand break repair is mediated by nuclease, polymerase, and
ligase enzymes, the DNA glycosylase enzyme starts removing the damaged base.6,7
1.2.2 NUCLEOTIDE EXCISION REPAIR:
Nucleotide excision repair is the preferred method for removing bulky lesions caused by
UV radiation, benzo[a]pyrene adducts, or chemotherapeutic agent damage, such as CPDs
and (6–4) PP. Universal genome NER (GG-NER) and transcription-coupled NER (TCNER) are the two main divisions of NER.7-9
6

The Xeroderma Pigmentosum complementation group C protein, which is complexed with
RAD23B protein and Centrin 2, is the key DNA damage sensor in GG-NER. This
complicated checks for the existence of transient single stranded DNA (ssDNA) triggered
by the lesion's disrupted base pairing. The ultraviolet-damaged DNA damage binding
protein complex, which consists of DDB1 and the GGNER-specific protein DDB2, directly
binds to UV-induced lesions and then activates the binding of XPC to repair UV-induced
CPDs. Figure 2
A lesion-stalled RNA polymerase II initiates the second NER pathway, TC-NER, Figure
2, which starts with the recruitment of TCNER-specific proteins CSA and Cockayne
syndrome protein B, which are needed for the additional assembly of other TCNER
components. UV stimulated scaffold protein A, ubiquitin specific processing protease 7,
XPA binding protein 2, and high mobility group nucleosome binding domain containing
protein 1 are examples of TCNER specific proteins. The CSA-CSB complex binds to the
lesion site and backtracks RNA polymerase II, revealing the lesion site. TFIIH is enlisted
to help with the lesion. As the lesion is separated from the transcribed strand, the sequence
of events is expected to be the same as in GG-NER.

7

Figure 2: Diagram of the TC-NER and GG-NER pathways9.
1.2.3 DOUBLE STRAND REPAIR MECHANISMS:
Homologous Repair is limited to the late S and G2 phases of the cell cycle, while nonhomologous end joining occurs during the cell cycle. Recombination using a homologous
template during DNA replication after recovery of stalled or broken replication forks
provides repair of DSBs and interstrand crosslinks in Homologous Repair, whereas in nonhomologous end joining, re-ligation of damaged DNA strand does not need a homologous
8

template for repair and thus has a strong repair capacity to include any kind of DNA ends.911

1.2.4 MISMATCH REPAIR MECHANISM:
Mismatch repair detects and repairs DNA mismatches and deletion loops caused by DNA
replication, with single strand incision mediated by nuclease, polymerase, and ligase
enzymes.9
1.3 ACTIVATION OF ATR-Chk1 AND ATM-Chk2 PATHWAYS
The ATM-Chk2 and ATR-Chk1 kinases are the two major signaling pathways activated
by DNA damage in vertebrates. In response to various DNA damages, the ATM-Chk2 and
ATR-Chk1 pathways are activated. ATR-Chk1 is triggered by replication stress caused by
lesions, whereas ATM-Chk2 is activated by DSBs. ATM is recruited and activates multiple
substrates such as H2AX, MRN complex, and Chk2's SQ/TQ-rich motif as a result of DSBs
caused by UV exposure.18 Chk2 also targets the p53 tumor suppressor protein, which is
involved in cell cycle development, apoptosis, and transcription. SsDNA is formed as a
result of replication fork stalling triggered by lesions or DSBs, which triggers ATR-Chk1.
When replication stalls, DNA polymerase stalls as well, resulting in long single strands of
unwinding DNA. RPA and ATR-ATRIP complexes bind to this ssDNA after that. ATR
activation and autophosphorylation activate downstream Chk1, causing cell cycle arrest
and the resumption of replication fork stalling by facilitating DNA repair.19,21 Though the
activation processes and downstream targets of ATM and ATR are distinct, they share
9

certain targets, such as p53 and H2AX, which are highly dependent on the form of
genotoxic stress.22-24

Figure 3: The ATM/ATR DNA damage response pathway and its downstream
effectors22
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1.4 ATR ACTIVATION IN NON-REPLICATING CELLS:
During cancer treatment, some of the chemotherapeutics used in the treatment are
genotoxic agents which damage the DNA of the cancerous cell leading to the death of
cancer cells. When there is DNA damage in these cells, ATR gets activated and tries to
protect these cells from the damage by activating cell cycle checkpoints, stabilizing stalled
replication forks, and by promoting DNA repair. Since UV photoproducts and other bulky
DNA lesions stall DNA polymerases only in cells that are actively replicating their DNA,
the function of ATR in response to DNA damage and transcription stress in nonreplicating, non-cycling cells is unknown.19,28,29
While previous research has shown that ATR can be triggered in non-cycling cells in
response to DNA repair intermediates and RNA polymerase stalling, the functional
significance of ATR in these situations in non-cycling cells has yet to be studied.30
There are certain studies done to prove that inhibition of ATR in these cancer cells, will
improve the chemotherapy treatment. This led to the invention of highly specific small
molecule ATR and ATM inhibitors by pharmaceutical companies.
1.5 NON-REPLICATING TERMINALLY DIFFERENTIATED STATE:
When acquiring specialized characteristics, terminally differentiated cells permanently
leave the mitotic cycle. TD cells can be induced to reenter the cell cycle in a variety of
ways, but they cannot be made to proliferate indefinitely because attempts to induce
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replication either result in cell death or indefinite growth arrest. This failure has so far
eluded biological understanding. Since terminally differentiated cells do not need genomic
replication, the transcription-coupled repair and differentiation-associated repair systems
are retained. Furthermore, long-lived terminally differentiated astrocytes retain nonhomologous end-joining DNA repair capability. These studies found that different
terminally differentiated or post-mitosis differentiating cells have reduced DNA repair
capacities and can use different DNA damage repair pathways to deal with both
endogenous and exogenous sources of DNA damage, depending on the intercellular
microenvironment. However, the molecular mechanisms underlying the decrease in DNA
repair ability in terminally differentiated cells remains unknown. A study shows that results
show that terminally differentiated cells are not confined to G0 but can partially reenter G1
in response to growth factors; they contribute to a much-needed definition of terminal
differentiation.31
Along with the rapidly growing cancer cells, the human body consists of other cells that
routinely undergo DNA replication and mitosis to regenerate tissues that make up the skin
and gut. However, the body primarily consists of many other different cells that reside in a
temporary or permanent non-replicating state. For example, quiescent cells temporarily
exit the cell cycle but can re-enter S phase upon stimulation with growth factor and/or other
signals. Other cell states characterized by a non-replicating state include senescence and
terminal differentiation.34 Upon telomere erosion or exposure to extreme stress, cells may
become senescent, in which they remain viable, contribute to tissue structure and function,
12

but are not capable of re-entering the cell cycle. Finally, organ development involves cells
undergoing terminal differentiation, where cells permanently exit the cell cycle and play
specialized functions unique to the specific tissue and organ. Indeed, most of the cells in
the body are in a terminally differentiated state. For example, the brain is composed of
terminally differentiated neurons, and there are numerous neurodegenerative diseases
states caused by defects in DNA repair genes. In addition, the keratinocytes that make up
the outer layer of the skin epidermis undergo terminal differentiation. These cells are
exposed to UVR on a daily basis and are known to contain cyclobutane pyrimidine dimers
(CPDs) and other UV photoproducts after UV exposure and to respond to the UV by
accumulating p53 protein.58 However, little is known about how differentiated cells
respond to DNA damage. The role of the ATR in non-replicating, differentiated cells has
never been examined. The purpose of this thesis project was to begin to understand the
function of ATR in differentiated keratinocytes in vitro and in human skin ex vivo. 31-33,46
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2.0 MATERIALS AND METHODS:
2.1 ATR INHIBITORS:
2.1.1 AZD67378:
AZD6738 is an ATP competitive, orally bioavailable inhibitor of the Serine/Threonine
protein kinase Ataxia Telangiectasia and Rad3 related (ATR). It was dissolved in DMSO
at a 3 mM stock concentration.
2.1.2 VE821:
VE-821 is a potent inhibitor of Serine/threonine protein kinase Ataxia Telangiectasia and
Rad3 related (ATR). It was dissolved in DMSO at a 10mM stock concentration.
2.2 CELL CULTURE:
Telomerase-immortalized normal human foreskin keratinocytes (N-TERTs) were cultured
in EpiLife medium containing human keratinocyte growth supplement (Thermo Fisher
Scientific), Human Keratinocyte Growth Supplement (is an additional supplement for the
growth of healthy cell, HKGS is specifically intended for its use in Epilife media helps in
growth of human keratinocytes) and penicillin/streptomycin. All cells were maintained in
a 5% CO2 humidified incubator at 37°C and monitored periodically for mycoplasma
contamination (Sigma Venor GeM Kit). The cells would reach confluence after plating by
3 days. These cells will be terminally differentiated by growing these cells in EpiLife media
containing high calcium (1.8 mM calcium) for 3-4 days. These cells were treated with an
14

ATR inhibitor (AZD6738 or VE-821) or DMSO vehicle for 30 minutes before the UV-B
exposure at different dose ranges.
2.3 MICROSCOPY:
Phase contrast microscopy (4X magnification) was used to examine cell morphology after
incubation of N-TERT keratinocytes in EpiLife medium containing either 2% FBS or
HKGS and lacking (-CaCl2) or containing in 1.8 mM CaCl2 (+CaCl2). Note that
proliferating N-TERTs are sensitive to prolonged growth at confluence in growth factordeprived medium, as the N-TERTs grown in the absence of CaCl2 begin to round.
2.4 PROTEIN IMMUNOBLOTTING:
Cells were scraped from the plate into cold PBS, pelleted, and lysed on ice in 20 mM TrisHCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, and 1% Triton X-100, and then
soluble lysates were prepared by centrifugation at maximum speed in a microcentrifuge for
10-15 min. Chromatin-associated proteins were enriched from cells following three
extractions with a modified cytoskeletal buffer (10 mM Tris-HCl pH 7.4, 100 mM NaCl,
3 mM MgCl2, 1 mM EDTA, 1 mM Na3VO4, 10 mM NaF, and 0.1% Triton X-100). Soluble
and chromatin lysates were separated by SDS-PAGE and then transferred to a
nitrocellulose membrane. Blots were probed with 1:2000 dilutions of antibodies against
phospho-KAP1 (Ser824; Bethyl A300-676A-M), phospho-p53 (Ser15; Cell Signaling
8284), phospho-CHK1 (Ser345, Cell Signaling); phospho-ATR (Thr1989; GeneTex
128145), PARP, CASPASE 3, Keratin 1, Keratin 5, or actin (Bethyl) overnight in TBST
15

(Tris-buffered saline containing 0.1% Tween-20). Chemiluminescence was visualized with
either Clarity Western ECL substrate (Bio-Rad) or SuperSignal West Femto substrate
(Thermo Scientific) using a Molecular Imager Chemi-Doc XRS+ imaging system. Signals
in the linear range of detection were quantified using Image Lab (Bio-Rad) and normalized.
2.5 DNA IMMUNOBLOTTING:
DNA was immobilized on nitrocellulose, dried, and immunoblotted for cyclobutane
pyrimidine dimers (CPDs) and 6,4 Photo products. For CPDs and 6,4 PP’s, cells were
harvested at the indicated time points following exposure to UV. Genomic DNA was
immobilized on the nitrocellulose membrane. An anti-thymine dimer-HRP monoclonal
antibody was used to detect CPDs and 6,4 PP’s presence.
2.6 CELL SURVIVAL ASSAY:
After pre-treating the cells with either DMSO or ATR inhibitor (VE-821 or AZD6738).
Cells were radiated to different UV-B doses. Then the cells were placed in the incubator
for three days. Cell survival was then measured by adding methylthiazolyldiphenyltetrazolium bromide (MTT) reagent. Then the cells were allowed to react with the reagent
for 2 hours and the absorbance of cells was measured using spectrophotometric detection.
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2.7 RT-QPCR:
N-TERTs were incubated with or without high calcium for 3 days in medium containing
HKGS or 2% FBS. RNA was purified from the cells and analyzed by RT-qPCR using
TaqMan probes against ATR and beta macroglobulin. Relative ATR mRNA expression
was measured.
2.8 SKIN EXPLANTS:
Punch biopsy samples (8 mm) from de-identified human skin discarded during
panniculectomy procedures were placed in hanging Millicell cell culture inserts (Millipore,
Burlington, MA) in wells of a 24-well plate containing Epilife culture medium containing
human keratinocyte growth factor. Patient consent for experiments was not required
because de-identified, leftover surgical human tissue is considered to be discarded material
by our institution, and thus the studies were exempt. Explants were kept in a 5% CO2
humidified incubator at 37 °C for up to 5 days after isolation. Experiments were initiated
1 day after beginning ex vivo culture, and medium containing the indicated compounds
was changed daily. At the indicated time points, biopsy samples were snap frozen in liquid
nitrogen or fixed in formalin. Sections were stained with hematoxylin and eosin to identify
apoptotic, “sunburn” epidermal cells and counted using Cytation 5 Cell Imaging MultiMode Reader. For western blotting, epidermis from skin biopsies was scraped and lysed in
RIPA buffer with Protease/Phosphatase Inhibitor. Lysates were prepared by sonification
and centrifugated at maximum speed following the steps in protein immunoblotting using
Caspase-3 Rabbit monoclonal antibody, Parp antibody (Cell signaling).
17

3.0 RESULTS:
3.1:

N-TERT

keratinocytes

exhibit

morphological

changes

indicative

of

differentiation upon treatment with a high concentration of calcium
Analysis of ATR function in terminally differentiated keratinocytes in vitro requires the
use of in cell culture conditions in which keratinocytes stop dividing and undergo terminal
differentiation. Addition of a high concentration of calcium to the culture media is standard
to many protocols for inducing keratinocyte differentiation in vitro.44,45 Using previous
protocols as a reference, N-TERT keratinocytes were incubated for several days in EpiLife
medium containing either a normal concentration of calcium (60 µM CaCl2) or high
concentration of calcium (1.8 mM) reported to be sufficient to induce differentiation. In
addition, N-TERTs were differentiated in the presence of either 2% FBS or human
keratinocyte growth supplement (HKGS), as low levels of growth factors have been
reported to facilitate differentiation.47 To check if the cells are undergoing differentiation,
morphological changes were monitored by phase contrast microscopy. As shown in Figure
4, cells displayed striking changes in morphology even with one day of treatment with 1.8
mM CaCl2. In addition to a decrease in cell proliferation and number, these changes
included the cells becoming more tightly linked to one another in groups of cells rather
than being more dispersed across the plate. At later time points, the cells become more
spindle shaped, especially for cells along the outer regions of the groups of cells.
Ultimately, cells start to shrink and come off of the plate. Interestingly, these
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morphological changes occurred at a faster rate in cells grown with 2% FBS than with
HKGS.
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Figure 4: Microscopic images of differentiated N-TERTs. Phase contrast microscopy
(4X magnification) was used to examine cell morphology after incubation of N-TERT
keratinocytes in EpiLife medium containing either 2% FBS or HKGS and lacking (-CaCl2)
or containing in 1.8 mM CaCl2 (+CaCl2). Note that proliferating N-TERTs are sensitive to
prolonged growth at confluence in growth factor-deprived medium, as the N-TERTs grown
in the absence of CaCl2 begin to round up and die after 4 or 8 days grown in low calciumcontaining medium containing 2% FBS or HKGS, respectively.

To confirm that the cells exposed to high calcium had indeed undergone terminal
differentiation and lost their ability to proliferate, N-TERTs grown for 3 days in either
normal medium (EpiLife medium containing HKGS) or medium containing 2% FBS and
1.8 mM CaCl2 were trypsinized and plated at low density to allow for clonogenic cell
growth. As shown in Figure 5, though the proliferating cells were capable of dividing to
form colonies containing large numbers of cells, the differentiated cells were unable to
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proliferate. We conclude from this experiment that N-TERTs treated with high calcium
undergo terminal differentiation and lose their ability to proliferate.

Figure 5: N-TERTs treated with high calcium lose their ability to proliferate. N-TERT
keratinocytes grown in EpiLife medium containing 2% FBS in the absence or presence of
high calcium for 1 day (proliferating) or 3 days (differentiated) were trypsizined and
counted. Two hundred cells were plated in a 3.5 cm diameter plate in normal growth
medium (EpiLife containing HKGS) and fed every 3-4 days with fresh medium. After 16
days, cells were fixed in methanol and stained with crystal violet to visualize colonies of
cells.
3.2: Keratinocytes undergoing differentiation exhibit changes in the expression of
keratins, ATR, and other markers of DNA synthesis and the DNA damage response.
One of the other methods to see if these cells are differentiated is by looking at the protein
levels of Keratin 5 and Keratin 1. The keratin 1 levels in a differentiated cell should be
higher than in a non-differentiated cell. Whereas the level of Keratin 5 in a differentiated
cell should be lower than a non-differentiated cell.47 As shown in Figure 6A, we have
observed a decrease in keratin 5 protein expression by immunoblotting in N-TERTs
cultured in high calcium and either HKGS or 2% FBS for 3 days. However, increased
keratin 1 was only observed in cells grown with FBS and 1.8 CaCl2 but not with cells
grown in HKGS. To examine this further, time course experiments were carried out in
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which cells were harvested for each day for analysis by immunoblotting. In cells grown in
the FBS and high calcium, keratin 1 levels became detectable after 2 days and continued
to increase after additional days of incubation. Keratin 5 began to decrease after 2-3 days
in high calcium (Figure 6B). In contrast, in cells grown in the HKGS and high calcium,
decreased keratin 5 expression was detectable at 6 days (Figure 6C) but was not correlated
with significant changes in keratin 1. However, as shown in Figure 6D, a keratin 1
antibody-reactive band below 35-kDa in molecular weight was observed specifically in NTERTs grown for 8 days in high calcium). Together, these results show that keratin protein
expression is altered by treatment with high calcium but that these changes are different in
N-TERTs grown in 2% FBS versus HKGS. Moreover, the more dramatic changes in
keratin expression in cells grown in 2% FBS are correlated with the more rapid changes in
cell morphology (Figure 4).
We have also looked at the protein levels of ATR and other DNA replication and DNA
damage response protein in cells undergoing differentiation. As shown in Figure 6A-D,
ATR protein expression decreased by approximately 3-fold within 3 days of culture in high
calcium regardless of growth factors. Correlated with the decreased expression of ATR
was a reduced expression of PCNA (proliferating cell nuclear antigen), which plays
essential roles in DNA replication. Where we have also observed that the levels of the
ATR-interacting protein ATRIP and DNA damage response kinases ATM and DNA-PK
(catalytic subunit) also exhibit reduced expression in N-TERTs undergoing differentiation
in high calcium.
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Figure 6. Western blots showing N-TERT differentiation and effects on ATR protein
levels. A) N-TERT keratinocytes were maintained for in EpiLife medium containing
HKGS or 2% FBS in the absence or presence of 1.8 mM CaCl2 for 3 days. Cell lysates
were prepared and analyzed by western blotting with antibodies against the indicated
proteins. The graph shows the quantitation of ATR protein levels from 3 independent
experiments performed as in A). The asterisks indicate significant differences in ATR
protein levels as determined by t-test (p<0.05). B) N-TERTs were analyzed as in A) except
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that cells were harvested at the indicated time points after addition of 2% FBS and 1.8 mM
CaCl2 to the culture medium. The graph shows the relative protein expression from 3
independent experiments. C) N-TERTs were maintained in EpiLife medium containing
HKGS with 1.8 mM CaCl2 for 0, 2, or 6 days and were then analyzed by western blotting.
D) Cells were treated as in C) except that cells were incubated for 8 days in high calcium.
The asterisk in D) indicates a possible degradation product of keratin 1 that is recognized
by the keratin 1 antibody only in cells treated with high calcium.
3.3: ATR expression is downregulated in differentiated cells.
To determine if the reduced levels of ATR in N-TERTs undergoing differentiation in high
calcium is also found at the mRNA level, RNA was purified from N-TERTs differentiated
in high calcium for 3 days in either HKGS or 2% FBS and then examined by RT-qPCR.
As shown in Figure 7, ATR mRNA levels were reduced by 2- to 2.5-fold by treatment
with high calcium. These results indicate that keratinocyte differentiation in vitro is
correlated with reduced ATR expression at both the mRNA and protein levels.
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Figure 7. RT-qPCR analysis of ATR expression at the RNA level in differentiated
cells. N-TERTs were incubated with or without high calcium for 3 days in medium
containing HKGS or 2% FBS. RNA was purified from the cells and analyzed by RT-qPCR
using TaqMan probes against ATR and beta macroglobulin. Relative ATR mRNA
expression was calculated from 3 independent experiments and graphed. The asterisks
indicate significant differences (t-tests, p<0.05).
3.4: Inhibition of ATR in differentiated cells does not have any effect on cell
proliferation or cell viability.
Though ATR expression decreases in keratinocytes undergoing differentiation, it is
possible that ATR kinase activity contributes to cell viability during this process. Thus, to
determine whether the inhibition of ATR kinase in the differentiated cells has any effect
over the cell survival, N-TERTs differentiated in high calcium and 2% FBS for 3 days were
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treated with various doses of the small molecule ATR inhibitors VE821 andAZD6738 for
an additional 3 days. MTT assays were then performed to monitor cell survival. As shown
in Figure 8, VE-821 had only a modest inhibitory effect on cell survival at the highest dose
(30 µM) but was not statistically different than untreated cells. AZD6738 had a similar
modest inhibition of cell number at 0.3 µM and above but was not dose dependent.

Figure 8. Effect of ATR kinase inhibition on cell proliferation/viability in
differentiated N-TERTs. N-TERTs maintained for 3 days in EpiLife medium containing
2% FBS and 1.8 mM CaCl2 were treated with increasing concentrations of the ATR
inhibitors AZD6738 or VE-821. MTT assays were performed 3 days later. The results show
the average (and SEM) from 3 independent experiments. One-way ANOVA was used to
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determine significant differences in survival between cells treated with the different doses
of the ATR inhibitors and the non-treated cells (p<0.05).
3.5: ATR is activated by UVB radiation in differentiated keratinocytes.
Though ATR protein expression is reduced in differentiated N-TERTs (Figure 6), the fact
the protein is still present suggests that it may contribute to DNA damage responses.
Indeed, previous studies have shown that ATR regulates cellular responses to UVB
radiation in quiescent keratinocytes.48 Thus, to determine if ATR kinase activity is involved
in DNA damage kinase signaling in differentiated keratinocytes, N-TERTs differentiated
for 3 days in 2% FBS and high calcium were exposed to UVB radiation and then harvested
for immunoblot analysis. As shown in Figure 9A, robust phosphorylation of both the tumor
suppressor protein p53 and the heterochromatin regulatory protein KAP1 was seen within
20 minutes of UVB exposure. Importantly, these phosphorylation events were completely
blocked by pre-treatment with the ATR inhibitor VE-821 (Figure 9A, B). To confirm these
findings with a second ATR inhibitor, N-TERTs differentiated with HKGS and high
calcium were treated with AZD6738 and then exposed to UVB. As shown in Figure 9C,
the UVB-dependent phosphorylation of KAP1 and p53 was blocked by AZD638 in
differentiated cells. This inhibition of phosphorylation was reduced when the N-TERTs
were grown in the proliferative state (without high calcium), consistent with a role for other
DNA damage response kinases such as ATM in mediating these responses in UVBirradiated proliferating keratinocytes. Lastly, though Chk1 is robustly phosphorylated after
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UVB in proliferating cells in an ATR-dependent manner, only low levels of Chk1
phosphorylation could be seen in the differentiated cells (Figure 9D).

Figure 9. Western blot data showing ATR- dependent phosphorylation of ATR
substrate proteins in UVB-irradiated differentiated N-TERTs. A) N-TERTs
differentiated for 3 days in medium containing 2% FBS and high calcium were treated with
vehicle (0.1% DMSO) or VE-821 (10 µM) for 30 min before exposure to 200 J/m2 UVB.
Cells were harvested 20 min later and analyzed by western blotting with antibodies against
the indicated proteins and phosphorylated residues. B) Quantitation of relative p53 and
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KAP1 phosphorylation (average and SEM) from 3 independent experiments. The asterisks
indicate significant difference (p<0.05, t-test). C) N-TERTs maintained in a proliferating
state or differentiated state (HKGS+high calcium) were pre-treated with vehicle or 3 µM
AZD6738 for 30 min before exposure to 200 J/m2 UVB. Cells were harvested and analyzed
by western blotting. D) Quantitation of relative Chk1 phosphorylation (average and SEM)
from 3 independent experiments. The asterisks indicate significant difference (p<0.05, ttest). N-TERTs maintained in a proliferating state or differentiated state (HKGS+high
calcium) were pre-treated with vehicle or 3 µM AZD6738 for 30 min before exposure to
200 J/m2 UVB. Cells were harvested and analyzed by western blotting.
3.6: ATR activation is dependent on the NER and transcription factor protein XPB.
The most widely recognized signal for ATR activation is stalled replication forks due to
insufficient deoxyribonucleotides or lesions that block DNA polymerase movement.59
Previous publications have shown that in non-replicating, quiescent cells, nucleotide
excision repair (NER) processing of UV lesions is required for ATR kinase signaling
(suggesting that the ssDNA gaps produced by NER are the signal that activates ATR).49-53
However, another study has suggested that stalled RNA polymerases may also activate
ATR,54 and thus there may be multiple mechanisms by which ATR can become activated
in non-replicating quiescent and differentiated cells in which no DNA synthesis is taking
place. To examine the mechanism of ATR activation in differentiated keratinocytes, NTERTS were differentiated and then treated with two inhibitors of the protein XPB, which
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plays essential roles in both NER and transcription.60 Spironolactone inhibits NER but not
transcription by inducing the proteolytic degradation of XPB.55,56 Triptolide inhibits NER
(and transcription) by covalently binding to XPB and inhibiting its ATPase activity.57
Hence, we have pre-treated differentiated N-TERTS with either DMSO, 10 µM
spironolactone or 1 µM triptolode for 30 minutes before exposure to 200 J/m2 UVB. Cells
were harvested 20 minutes after for western blot analysis. We observed that both TPL and
spironolactone inhibited the phosphorylation of KAP1 and p53 induced by UVB radiation
(Figure 10 A, B). Analysis of ATM/ATR substrate phosphorylation with a mixture of
antibodies targeting ATR and ATM substrates similarly revealed that the majority of
substrate phosphorylation induced by UVB is dependent upon XPB function. These results
indicate that NER is important for ATR activation in differentiated keratinocytes exposed
to UVB radiation.
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Figure 10. ATR activation in UVB-irradiated differentiated N-TERTs requires the
NER and transcription factor XPB. N-TERTs differentiated with 2% FBS and high
calcium for 3 days were pre-treated with either A) triptolide (1 µM TPL, 30 min) or B)
spironolactone (10 µM SP, 2 hr) and then exposed to 200 J/m2 UVB. Cells were harvested
20 min later and analyzed by western blotting with antibodies against the indicated
proteins.
3.7: Inhibition of ATR kinase protects differentiated keratinocytes from UV
irradiation.
To further explore the function of ATR in differentiated keratinocytes, MTT (3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell viability assays were
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conducted in N-TERTs undergoing the process of differentiation for increasing numbers
of days. In all experiments, the cells were pre-treated with either DMSO or ATR inhibitor
for 30 minutes, irradiated with UV-B at different doses, and then incubated for additional
3 days. MTT reagent was added in the media, incubated for 2 hours, and then the
absorbance was measured. In proliferating cells, treatment with the ATR inhibitor VE-821
modestly sensitized the cells to low doses of UVB radiation (Figure 11A). Similar results
were observed in cells differentiated with calcium for only 1 day (Figure 11B). However,
after additional days of differentiation, the effect of ATR inhibition began to change, such
that cells treated with the ATR inhibitor became progressively more resistant to UVB than
the vehicle-treated cells (Figure 11 C-E).
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Figure 11. The effect of the ATR inhibitor VE-821 on UVB survival changes during
the course of keratinocyte differentiation in vitro. A) N-TERT keratinocytes grown in
normal medium were treated with vehicle (DMSO, 0.1%) or VE-821 (10 µM) for 30 min
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before exposure to the indicated fluence of UVB radiation. MTT assays were performed 3
days later. B-E) N-TERTs were differentiated for 1-4 days in medium containing 2% FBS
and 1.8 mM CaCl2 and then treated as in A). Results show the average and SEM from three
independent experiments. T-tests were used to compare the level of survival between the
DMSO- and VE821 treatment groups at each UVB dose and time point (p<0.05).

As another way of representing this survival data, we graphed the relative survival of UVBirradiated N-TERTs as a function of ATR inhibition and days of differentiation on a single
graph. As shown in Figure 12A, the sensitivity of vehicle-treated N-TERTs to 50 J/m2
UVB was similar regardless of period of differentiation. In contrast, whereas the
proliferating and early-stage differentiated N-TERTs were sensitized to UVB when ATR
was inhibited, the cells become slightly more resistant to UVB after 3-4 days of
differentiation. Similar results were observed in N-TERTs exposed to 100 J/m2 UVB
(Figure 12B). These results imply that the function of ATR in UVB survival changes
during differentiation.
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Figure 12. The effect of the ATR kinase inhibitor VE-821 on UVB survival changes
as a function of keratinocyte differentiation. UVB survival data were re-graphed as a
function of days of differentiation for cells exposed to A) 50 J/m2 UVB or B) 100 J/m2
UVB. Results show the average (and SEM) level of survival from 3 independent
experiments. T-tests were used to compare the level of survival between the DMSO- and
VE821 treatment groups at each UVB dose and time point (p<0.05).

To confirm the protective effect of ATR inhibition in differentiated keratinocytes against
UVB exposure, N-TERTs differentiated with HKGS and high calcium were treated with
vehicle or 3 µM AZD6738 and then exposed to increasing fluences of UVB radiation. As
shown in Figure 13A, cells treated with AZD6738 exhibited higher levels of survival at
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multiple UVB doses than vehicle-treated cells. Similar results were observed with cells
were treated with 6 µM AZD6738.
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Figure
22 13. The effect of the ATR kinase inhibitor AZD6738 on UVB survival in
differentiated keratinocytes. N-TERT keratinocytes were differentiated with HKGS and
high calcium for 3 days and then exposed to increasing doses of UVB after pre-treatment
with DMSO and A) 3 µM AZD6738 or B) 6 µM AZD6738. Results show the relative
survival (average and SEM) from 3 independent experiments. T-tests were used to compare
survival in the two treatment groups at each UVB dose.

3.8: ATR kinase promotes apoptotic signaling in differentiated keratinocytes.
To further confirm that inhibition of ATR kinase in these differentiated cells would protect
the cells from UVB exposure, N-TERTs were differentiated for four days with HKGS and
high calcium, pre-treated with either DMSO or ATR inhibitor AZD6738 for 30 minutes,
and then irradiated with UV-B at 100 J/m2. Cells were harvested after 10 hours to look at
the apoptotic signaling through western blot analysis of the cleaved form of PARP. = As
shown in Figure 14, we observed reduced levels of cleaved PARP in cells in which ATR
was inhibited. These results suggest that ATR inhibition leads to reduced apoptotic
signaling in the differentiated cells.
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Figure 14. Effect of ATR kinase inhibition on apoptotic signaling Cleaved PARP.
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N-TERTs were differentiated for 4 days in HKGS and high calcium before treatment with
vehicle (DMSO) or AZD6738 and exposure to UVB. Cells were harvested 10 hours later
for western blot analysis. The graph shows the relative level of cleaved PARP in the
different conditions. A.) N-TERTs differentiated for 3 days in medium containing 2%
HKGS and high calcium were treated with vehicle (0.1% DMSO) or AZD6738 (3 µM) for
30 min before exposure to 100 J/m2 UVB. Cells were harvested 20 min later and analyzed
by western blotting with antibodies against the indicated proteins and phosphorylated
residues. B) Quantitation of cleaved PARP (average and SEM) from 2 independent
experiments.

3.9: ATR kinase inhibition helps in removal of CPD’s in differentiated keratinocytes.
To further confirm that inhibition of ATR kinase in these differentiated cells would protect
the cells from UVB exposure, N-TERTs were differentiated for four days with HKGS and
high calcium, pre-treated with either DMSO or ATR inhibitor AZD6738 for 30 minutes,
and then irradiated with UV-B at 100 J/m2. Cells were harvested at different time points
to look at the percentage of CPD present through immunoblot analysis of the CPD. = As
shown in Figure 15, we observed that inhibition of ATR does not have any effect on the
CPDs repair.
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Figure 15. Effect of ATR inhibition on CPD removal. N-TERTs were differentiated for
four days with HKGS and high calcium, pre-treated with either DMSO or ATR inhibitor
AZD6738 for 30 minutes, and then irradiated with UV-B at 100 J/m2. Cells were harvested
at different time points to look at the percentage of CPD present through immunoblot
analysis of the CPD.

3.10: ATR kinase activity is important for apoptosis in human skin epidermis.
As UVB penetrates through the epidermal layer, the function of ATR kinase was
investigated in human skin epidermal explants maintained in growth media. The epidermal
explants were treated with vehicle DMSO and ATR inhibitor AZD6738 and exposed to
UVB 800 J/m2. We conducted H&E immunostaining to look at the effect of ATR inhibition
on the formation of apoptotic “sunburn” cells. ATR inhibition significantly reduced the
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number of sunburn cells on the epidermal layer which suggests that ATR kinase facilitates
apoptosis in human skin epidermal cells (Figure 16A).
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Figure 16. ATR inhibition in human skin ex vivo reduces sunburn cell formation.
Human were pre-treated with either DMSO or ATR inhibitor AZD6738 for 30 minutes and
then irradiated with UV-B at 800 J/m2. The skin punch biopsies were collected 24 hours
after the treatment. A. H&E (Haemotoxylin and Eosin) staining was used to identify and
quantify apoptotic “sunburn” cells along the entire length of the biopsy, C. Representative
microscopic images of H&E-stained human skin treated with DMSO or AZD6738 and
exposed to UVB exposure.
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DISCUSSION
Cells that are actively replicating are routinely used to investigate the role of ATR kinase
activation and its functions in response to DNA damaging agents. Because of ATR kinase's
pro-survival function, its inhibition has been proposed as an effective adjuvant therapy with
chemotherapy to sensitize cancer cells and improve chemotherapeutic impact. However,
in non-cycling/non-replicating cells exposed to genotoxic agents, the role of ATR kinase
activation is unknown. Initial research using a non-replicating cell model using serumdepleted keratinocytes HaCaT revealed that when non-replicating cells are exposed to
UVC or the UV mimetic N-acetyoxy-2-acetylaminofluorene, ATR is activated by
transcription stress and was thought to have pro-apoptotic properties (Kemp, JBC 2016).
More recent works have revealed roles of NER in ATR activation and a pro-survival/antimutagenic function of ATR in serum-starved, quiescent cells exposed to either UVB
radiation or cisplatin (Shaj et al, Photochemistry & Photobiology 2020; Hutcherson et al,
Mutation Research 2019). The striking difference in the role of ATR kinase in both models
was verified by the comparison of replicating cells activating ATR in response to
replication stress and exhibiting pro-survival functions versus non-replicating cells
activating ATR in response to transcription stress and exhibiting pro-apoptotic functions.
This prompted us to investigate the function of ATR kinase in differentiated cell models.
We hypothesized that inhibition of ATR may have different outcomes in terminally
differentiated cells.
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The model that we have used in this study is the human epidermal keratinocytes (NTERTS) induced to undergo terminal differentiation by treatment with a high concentration
of calcium in EpiLife medium containing either human keratinocyte growth supplement or
2% FBS. To confirm that the cells were terminally differentiated, we examined the
morphological changes (Figure 4,5) and measured the keratin levels in the cells 47 (Figure
6A-6D). We also measured the levels of ATR and other DNA replication and DNA damage
response protein in cells undergoing differentiation. As shown in Figure 6A-D, ATR
protein expression decreased by approximately 3-fold within 3 days of culture in high
calcium regardless of growth factors. Correlated with the decreased expression of ATR
was a reduced expression of PCNA (proliferating cell nuclear antigen), which plays
essential roles in DNA replication. We have also observed that the levels of the ATRinteracting protein ATRIP and DNA damage response kinases ATM and DNA-PK
(catalytic subunit) were also reduced in N-TERT cells undergoing differentiation in high
calcium. To further confirm the effect of differentiation on ATR levels, the mRNA levels
of ATR have been measured by RT-QPCR. As shown in Figure 7, ATR mRNA levels
were reduced by 2- to 2.5-fold by treatment with high calcium. These results indicate that
keratinocyte differentiation in vitro is correlated with reduced ATR expression at both the
mRNA and protein levels.
To investigate if ATR inhibitors have any effect on the cell survival in the differentiated
cells, N-TERTs differentiated in high calcium and 2% FBS for 3 days were treated with
various doses of the small molecule ATR inhibitors VE821 and AZD6738 for additional 3
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days. MTT assays were then performed to monitor cell survival. As shown in Figure 8,
VE-821 had only a modest inhibitory effect on cell survival at the highest dose tested (30
µM). AZD6738 had a similar modest inhibition of cell number at 0.3 µM and above but
the effect was not dose dependent. We have investigated if whether or not ATR is activated
after differentiated cells are exposed to UVB and also looked if the ATR inhibitors that we
have been using block the ATR and its substrates. As shown in Figure 9A, robust
phosphorylation of both the tumor suppressor protein p53 and the heterochromatin
regulatory protein KAP1 was observed within 20 minutes after UVB exposure.
Importantly, these phosphorylation events were completely blocked by pre-treatment with
the ATR inhibitor VE-821 (Figure 9A, B). To confirm these findings with a second ATR
inhibitor, N-TERTs differentiated with HKGS and high calcium were treated with
AZD6738 and then exposed to UVB. As shown in Figure 9C, the UVB-dependent
phosphorylation of KAP1 and p53 was blocked by AZD638 in differentiated cells. This
inhibition of phosphorylation was reduced when the N-TERTs were grown in the
proliferative state (without high calcium), consistent with a role for other DNA damage
response kinases such as ATM in mediating these responses in UVB-irradiated
proliferating keratinocytes. Lastly, though Chk1 is robustly phosphorylated after UVB in
proliferating cells in an ATR-dependent manner, only low levels of Chk1 phosphorylation
could be seen in the differentiated cells (Figure 9D).
To examine whether ATR activation is dependent on the nucleotide excision repair and
transcription factor protein XPB. We observed that both TPL and spironolactone inhibited
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the phosphorylation of KAP1 and p53 induced by UVB radiation (Figure 10 A, B).
Analysis of ATM/ATR substrate phosphorylation with a mixture of antibodies targeting
ATR and ATM substrates similarly revealed that the majority of substrate phosphorylation
induced by UVB is dependent upon XPB function. These results indicate that NER is
important for ATR activation in differentiated keratinocytes exposed to UVB radiation.
Based on our hypothesis that inhibition of ATR in UVB irradiated terminally differentiated
cells and human skin would have a pro-survival role, we have investigated the protective
effects of ATR inhibitors over the differentiated cells. MTT cell viability assays were
conducted in N-TERTs undergoing the process of differentiation for increasing numbers
of days. In proliferating cells, treatment with VE-821 modestly sensitized the cells to low
doses of UVB radiation (Figure 11A). Similar results were observed in cells differentiated
with calcium for only 1 day (Figure 11B). However, after additional days of
differentiation, the effect of ATR inhibition began to change such that cells treated with
the ATR inhibitor became progressively more resistant to UVB than the vehicle-treated
cells (Figure 11 C-E). To confirm the protective effect of ATR inhibition in differentiated
keratinocytes against UVB exposure, N-TERTs differentiated with HKGS and high
calcium were treated with 3 µM AZD6738 or vehicle and then exposed to increasing
fluences of UVB radiation. As shown in Figure 13A, cells treated with AZD6738 exhibited
higher levels of survival at multiple UVB doses than the vehicle-treated cells. Similar
results were observed with cells that were treated with 6 µM AZD6738.
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To investigate whether ATR kinase promotes apoptotic signaling in differentiated cells and
would protect the cells from UVB exposure. Cells were harvested after 10 hours for the
examination of the apoptotic signaling through western blot analysis of the cleaved form
of PARP. As shown in Figure 14, we observed reduced levels of cleaved PARP in cells
with inhibited ATR. These results suggest that ATR inhibition leads to reduced apoptotic
signaling in the differentiated cells. To investigate whether inhibition of ATR in the
differentiated cell would help in the removal of CPD after UVB exposure. Cells were
harvested at different time points to measure the levels of CPD present through immunoblot
analysis. As shown in Figure 15, we observed reduced levels of CPDs in cells in which
ATR was inhibited at 12 hour and 24-hour time points.
Experiments with ex-vivo human skin explants were also conducted to examine the role of
ATR kinase. We have tried to examine the apoptotic signaling levels in the human skin,
but was unable to see at any cleaved Caspase 3 or cleaved PARP, which could potentially
be caused by different treatment of the samples by applying ATR inhibitors topically over
the skin. It is also unknown how long it takes for the Caspase 3 or PARP to completely
release (cleaved?). The punch biopsies for the caspase 3 were taken around 12 hours after
UVB irradiation and the biopsies for PARP have been taken after 18 hours after UVB
irradiation. they could have been different as well. The skin was irradiated with 800 J/m2
of UVB dose, maybe the dose of UVB should be increased be increased to look at the levels
of PARP or Caspase 3. The immunohistochemistry of human skin epidermis showed a
decrease in apoptotic “sunburn” cells caused due to UVB irradiation when treated with
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ATR inhibitor AZD6738 than in DMSO-treated skin samples. With the skin experiments,
we have faced some challenges. It is not so well known about the doses of ATR inhibitor
to be used? what exact dose of UVB could cause DNA damage? at what time point would
apoptotic signaling can be seen? What is best way to administer the dose? There are so
many unknown questions with the skin experiments. We also tried looking at the PARP
and CASPASE 3 for apoptotic signal through western blotting but failed to get a signal.
Over the past three decades, Ultraviolet radiation that has been reaching the earth’s surface
has increased. One of the common risks of this UVB radiation is DNA damage. The DNA
damage caused by this UVB radiation has a strong tendency of converting DNA damage
to malignant melanoma. Most of the epidermal keratinocytes that are exposed to the UVB
radiation are in non-replicating differentiated states. The data we have generated so far
indicate that ATR, an important DNA damage response protein kinase, has different
functions depending on the differentiated cell states and types of DNA damage. It has a
pro-survival role in proliferating cells or serum-starved, confluence cells which actively
replicate DNA after exposure to UVB radiation or the anti-cancer drug cisplatin. In
contrast, the data presented here suggests that ATR has a pro-apoptotic role in in nonreplicating terminally differentiated cells. These results have likely implications for the use
of ATR kinase inhibitors in humans, which are currently undergoing clinical trials for
cancer therapy alone or in combination with DNA damage-based anti-cancer drugs. It is
possible that ATR inhibitors may have protective functions in terminally differentiated
cells that often show side effects during cancer treatment, such as neurons in the brain.
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APPENDIX
6-4 PP

–

6-4 Photoproducts

ATM

–

Ataxia-telangiectasia mutated

ATR

–

Ataxia-telangiectasia mutated and Rad 3-related

ATR-ATRIP

–

ATR – interacting protein

ATRi

–

ATR Inhibitor

BER

–

Base excision Repair

BrdU

–

Bromodeoxyuridine

Chk1

–

Checkpoint kinase 1

Chk2

-

Checkpoint kinase 2

CPD

–

Cyclobutene dimers

CSA/CSB

–

Cockayne Syndrome proteins

DDBs

–

Damaged DNA Binding proteins

DDR

–

DNA Damage Repair

DNA

–

De-oxy ribose nucleic acid

DSBs

–

Double Strand Breaks EU- 5 ethynyl uridine

GG-NER
Eosin

–

Global genome Nucleotide excision repair H&E – Haemotoxylin and

H2AX

–
Histone H2A X variant HPRT - hypoxanthine-guanine
phosphoribosyltransferase

HR

–

Homologous Recombination

IR

–

Ionizing radiation

KAP1

–

KRAB-associated protein-1

MMR

–

Mismatch Repair

NER

–

Nucleotide excision Repair

NHEJ

–

Non – homologous end joining PCNA – Proliferating cell nuclear antigen
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PIKKs

–

Phosphoatidylinositol-3 kinase-like kinases

RPA

–

Replication protein A

SP

–

Spironolactone

SsDNA

–

Single-stranded DNA

TC-NER

–

Transcription – coupled Nucleotide Excision Repair

TFIIH

–

Transcription factor II H TLS – Translesion Synthesis

TPL

-

Triptolide

UVA

–

Ultraviolet Radiation A

UVB

–

Ultraviolet Radiation B

UVC

–

Ultraviolet Radiation C

UVR

–

Ultraviolet Radiation

XPB

–

Xeroderma pigmentosum complementation group B
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